Home - Products - Others - Other Targets - Neuropeptide Y (13-36) (porcine)

Neuropeptide Y (13-36) (porcine)

CAS No. 113662-54-7

Neuropeptide Y (13-36) (porcine)( ——— )

Catalog No. M40290 CAS No. 113662-54-7

Neuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 500 In Stock
10MG 786 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Neuropeptide Y (13-36) (porcine)
  • Note
    Research use only, not for human use.
  • Brief Description
    Neuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist.
  • Description
    Neuropeptide Y (13-36), porcine is a selective neuropeptide Y2 receptor agonist.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    113662-54-7
  • Formula Weight
    2982.408
  • Molecular Formula
    C135H209N41O36
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL (16.77 mM; ultraphonic; ) H2O : ≥ 50 mg/mL (16.77 mM)
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Aguirre JA, et al. Centrally injected neuropeptide Y (13-36) produces vasopressor effects and antagonizes the vasodepressor action of neuropeptide Y (1-36) in the awake male rat. Neurosci Lett. 1990 Oct 2;118(1):5-8.?
molnova catalog
related products
  • (S)-3-AMino-2-Methyl...

    (S)-3-AMino-2-Methylpropanoic acid-HCl is a chemical compound.

  • Fallacinol

    Fallacinol has antioxidant activity.

  • RI-STAD 2

    AKAP disruptor. Selectively binds PKA-RI with high affinity (KD values are 6.2 and 12.1 nM for the RIα and β subunits, respectively) and blocks its interaction with AKAP. Inhibits type I PKA-mediated phosphorylation in live cells. Cell permeable.